Perkins Coie Advises Cleerly on IP Strategy for $106M Financing

NEW YORK (December 10, 2024)—Perkins Coie is pleased to have advised Cleerly, a leader in advanced cardiovascular imaging, on its intellectual property strategy as part of its $106 million Series C extension funding round. For more information, please see Cleerly’s press release here.

With this new funding, Cleerly will continue to scale its commercial growth and clinical evidence generation, helping health care professionals improve outcomes for patients across the coronary care pathway. Cleerly is dedicated to creating a new standard of care for heart disease by utilizing FDA-cleared solutions powered by artificial intelligence.

The Perkins Coie legal team that advised Cleerly included partners Zach Hong and Thomas Yee, counsel Bryan Johnson, and associate Jason Francis. 

The internationally recognized Intellectual Property practice at Perkins Coie consists of more than 275 lawyers and agents in the United States and Asia, over 80 percent of whom have degrees in science, technology, engineering, and math (STEM). 

Our IP team, which provides innovative, collaborative counsel at every stage of IP protection and development, has facilitated patent and portfolio purchases and sales totaling hundreds of millions of dollars, venture funding totaling billions of dollars, and acquisitions and initial public offerings totaling in the tens of billions of dollars.